It

Prescription products · Product label record

Itvisma community

ONASEMNOGENE ABEPARVOVEC-BRVE
Novartis Innovative Technologies Inc. · INTRATHECAL

Product NDC: 71894-200

Explore drug database
CommunityExperiencesReviewsDrug database

About this product community

Discuss Itvisma supplied by Novartis Innovative Technologies Inc. for the intrathecal route. Product codes: 71894-200. Check the name, labeler and route on your packaging before comparing experiences.

Forms and strengths in the label: 3 DOSAGE FORMS AND STRENGTHS ITVISMA is a clear to slightly opaque, colorless to faint white suspension for intrathecal injection. Each single-dose vial contains 1.2 × 10 14 vg of onasemnogene abeparvovec in 3 mL of suspension. ITVISMA has a nominal concentration of 4 × 10 13 vg/mL, and each vial contains an extractable volume of not less than 3 mL Read the source section

Useful topics include starting treatment, everyday routines, side effects you discussed with your clinician, and access to this product. This space has no patient rating until a visitor submits a review.

Read 22 sections from the product label · Original label on DailyMed
Share your own experience. Community posts are not medical advice; speak with your clinician before changing treatment.

Community conversations

Start a conversation

Be the first to share your experience

No patient contributions yet. Start a conversation about this specific product.

No posts in this category yet. Your experience could help the next person.